Safety and Efficacy of Vilazodone in Major Depressive Disorder
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the efficacy, safety, and tolerability of 2 fixed
dose levels of vilazodone compared to placebo in patients with major depressive disorder.